
    
      Based on our previous experience with the use of a weekly paclitaxel dose of 60 mg/m2 and
      hyperfractionated radiation therapy 63.8 Gy, we are conducting this study incorporating the
      use of Gemcitabine at a dose level of 75 mg/m2/week in addition to our prior protocol.
    
  